Artículos por temáticas

Longitudinally persisting KCNA2-autoantibodies in mild amnestic dementia with Alzheimer´s pathology - Report and literature review

Hansen N, Teegen B, Hirschel S, Fox J, Fitzner D, Wiltfang J, Bartels C.

Behav Brain Res. 2025 Mar 28;482:115437. doi: 10.1016/j.bbr.2025.115437. Epub 2025 Jan 22.

Comparing Emotional Valence from Human Quantitative Ratings and Qualitative Narrative Data on Using Artificial Intelligence to Reduce Caregiving Disparity

Yoon S, Crupi R, Sun F, Tipiani D, Patterson M, Pottinger T, Kim M, Davis N.

Stud Health Technol Inform. 2025 Apr 8;323:1-5. doi: 10.3233/SHTI250036.

Epigallocatechin-3-Gallate Inhibits Oxidative Stress Through the Keap1/Nrf2 Signaling Pathway to Improve Alzheimer Disease

Tang S, Zhang Y, Botchway BOA, Wang X, Huang M, Liu X.

Mol Neurobiol. 2025 Mar;62(3):3493-3507. doi: 10.1007/s12035-024-04498-6. Epub 2024 Sep 20.

Design, current states, and challenges of nanomaterials in anti-neuroinflammation: A perspective on Alzheimer's disease

Hong X, Chen T, Liu Y, Li J, Huang D, Ye K, Liao W, Wang Y, Liu M, Luan P.

Ageing Res Rev. 2025 Mar;105:102669. doi: 10.1016/j.arr.2025.102669. Epub 2025 Jan 27.

Drug repurposing using artificial intelligence, molecular docking, and hybrid approaches: A comprehensive review in general diseases vs Alzheimer's disease

Zulhafiz NA, Teoh TC, Chin AV, Chang SW.

Comput Methods Programs Biomed. 2025 Apr;261:108604. doi: 10.1016/j.cmpb.2025.108604. Epub 2025 Jan 13.

Mitochondria-targeting by small molecules against Alzheimer's disease: A mechanistic perspective

Pal C.

Biochim Biophys Acta Mol Basis Dis. 2025 Mar;1871(3):167617. doi: 10.1016/j.bbadis.2024.167617. Epub 2024 Dec 8.

Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer's disease

Karati D, Meur S, Roy S, Mukherjee S, Debnath B, Jha SK, Sarkar BK, Naskar S, Ghosh P.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Mar;398(3):2319-2342. doi: 10.1007/s00210-024-03500-1. Epub 2024 Oct 21.

Brexpiprazole for the Treatment of Agitation in Alzheimer's Disease Dementia: Clinical Uncertainties and the Path Forward

Aga VM.

Am J Geriatr Psychiatry. 2025 Mar;33(3):322-329. doi: 10.1016/j.jagp.2024.11.003. Epub 2024 Nov 19.

A review: From old drugs to new solutions: The role of repositioning in alzheimer's disease treatment

Shah FA, Qadir H, Khan JZ, Faheem M.

Neuroscience. 2025 Jun 7;576:167-181. doi: 10.1016/j.neuroscience.2025.03.064. Epub 2025 Mar 29.

Cholinesterase-based inhibitors as multitarget small molecules for the therapy of Alzheimer's disease

Marco-Contelles JL, Oset-Gasque MJ.

Chem Biol Interact. 2025 May 25;413:111497. doi: 10.1016/j.cbi.2025.111497. Epub 2025 Mar 28.

The role of low-level laser therapy in Alzheimer's disease: a review of the potential benefits of vitamin D enhancement

Firoozi A, Shadi M, Rezagholizadeh A.

Lasers Med Sci. 2025 Mar 25;40(1):159. doi: 10.1007/s10103-025-04407-w.

IPECAD Modeling Workshop 2023 Cross-Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease

Handels R, Herring WL, Kamgar F, Aye S, Tate A, Green C, Gustavsson A, Wimo A, Winblad B, Sköldunger A, Raket LL, Stellick CB, Spackman E, Hlávka J, Wei Y, Mar J, Soto-Gordoa M, de Kok I, Brück C, And

Value Health. 2025 Apr;28(4):497-510. doi: 10.1016/j.jval.2024.09.006. Epub 2024 Oct 8.

Improving executive functioning and reducing the risk of Alzheimer's disease with music therapy: A narrative review of potential neural mechanisms

Slade B, Williams B, Engelbrecht R, Ciorciari J.

J Alzheimers Dis. 2025 May;105(2):319-330. doi: 10.1177/13872877251327762. Epub 2025 Mar 24.

Protective effect of flavonoids on oxidative stress injury in Alzheimer's disease

Wang K, Chen X.

Nat Prod Res. 2025 Mar;39(5):1272-1299. doi: 10.1080/14786419.2024.2345760. Epub 2024 Jun 23.

Role of RhoA-ROCK signaling inhibitor fasudil in Alzheimer disease

Al-Kuraishy HM, Sulaiman GM, Mohammed HA, Al-Gareeb AI, Albuhadily AK, Mohammed SG.

Behav Brain Res. 2025 Apr 27;484:115524. doi: 10.1016/j.bbr.2025.115524. Epub 2025 Mar 3.